Source document or public record

FDA 510(k) K221885 — 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports

FDA 510(k) index record K221885. Device: 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports. Applicant as listed: 23AndMe, Inc.. Decision date: 2022-10-26.

OtherU.S. Food and Drug Administration (FDA)2022-10-26

Source

"device_name": "23andMe Personal Genome Service (PGS) Pharmacogenetic Reports"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K221885.

Device name: 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports. Applicant as listed: 23AndMe, Inc..

Decision date: 2022-10-26. Decision wording: Substantially Equivalent.

Product code: QDJ. Regulation: 21 CFR 862.3364. Medical specialty: Medical Genetics.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.